PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.97%
Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.
92.74%
Gross profit growth above 1.5x CVE's 7.22%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
9.56%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
9.56%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
49.12%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
50.78%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
51.18%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.45%
Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.
1.38%
Positive OCF growth while CVE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.62%
Positive FCF growth while CVE is negative. John Neff would see a strong competitive edge in net cash generation.
-42.48%
Negative 10Y revenue/share CAGR while CVE stands at 14.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
25.40%
5Y revenue/share CAGR under 50% of CVE's 86.95%. Michael Burry would suspect a significant competitive gap or product weakness.
27.45%
3Y revenue/share CAGR above 1.5x CVE's 15.82%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-16.96%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
36.47%
Below 50% of CVE's 97.24%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
23.48%
3Y OCF/share CAGR at 75-90% of CVE's 26.33%. Bill Ackman would press for improvements in margin or overhead to catch up.
-89.79%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
243.51%
5Y net income/share CAGR 1.25-1.5x CVE's 191.57%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
790.85%
3Y net income/share CAGR above 1.5x CVE's 62.48%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-36.56%
Negative equity/share CAGR over 10 years while CVE stands at 12.84%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
8.42%
5Y equity/share CAGR above 1.5x CVE's 2.33%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
175.31%
3Y equity/share CAGR above 1.5x CVE's 32.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-13.51%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
228.10%
5Y dividend/share CAGR at 75-90% of CVE's 274.57%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
106.82%
Below 50% of CVE's 738.67%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
6.20%
Our AR growth while CVE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
257.99%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.78%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-3.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.49%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.